M&APierre Fabre Laboratories acquires Vertica...French pharma company Pierre Fabre Laboratories has baged Vertical Bio to push development of the companys NSCLC candidate. more ➔ C more ➔
FinancingBioLamina AB bags €19m funding for expan...French-US-based investment specialist Lauxera Capital Partners announced today that it has invested €17m in Swedish cell culture company BioLamina AB (BioLamina) more ➔
radiopharmaceuticalRadiotherapy R&D partnershipOrano Med SAS and Orbit Discovery Ltd announced a collaboration to develop Peptide Receptor Radionuclide Therapies for cancer cells and develop novel radiopharmaceuticals. more ➔
Tech transferBioInnovation Institute Boosts Six Life Sc...Non-profit foundation BioInnovation Institute (BII) has unveiled its latest commitment to driving innovation and growth within the life science sector. Six promising companies will receive crucial financial … more ➔
NGTMajority of EU agri-council supports NGT d...At a council meeting, a majority of EU agriculture ministers have supported the draft regulation on new genomic technologies (NGT) proposed by the EU Commission in early July. more ➔
New detection method for protein degraders German researchers have developed a new way to detect the about 300 cullin-RING ligases (CRLs) which specifically trigger destruction of specific proteins in the cell. more ➔
ScienceStudy: New breeding methods hardly contrib...According to Swiss bioethicists, deregulation of genetic engineering rules for plants optimised through targeted mutation and cisgenetics will make little contribution to climate protection by 2050. more ➔
vaccinesCEPI commits up to US$80m to University of...The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of globally accessible vaccines against … more ➔
Agri-biotechPairwise and Bayer collaborate to CRISPR s...Bayer and Pairwise extend their collaboration in precision breeding for five further years to develop CRISPR applications for Bayer’s Preceon Smart Corn System. more ➔
FinancingMystery solved: Mysthera Theapeutics launc...Mysthera Therapeutics AG has launched in Basel with $3.5m in seed funding from founding investor Forty51 Ventures. The capital will be used to advance its preclinical portfolio in a variety of autoimmune … more ➔
